These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 7920440)
1. Inhibitory effect of clindamycin on production of beta-lactamase in beta-lactam-resistant bacteria. Nishihata T; Kunieda S; Nakahama C; Soejima R Biol Pharm Bull; 1994 May; 17(5):715-20. PubMed ID: 7920440 [TBL] [Abstract][Full Text] [Related]
2. Factors that influence the evolution of beta-lactam resistance in beta-lactamase-inducible strains of Enterobacter cloacae and Pseudomonas aeruginosa. Aronoff SC; Shlaes DM J Infect Dis; 1987 May; 155(5):936-41. PubMed ID: 3104483 [TBL] [Abstract][Full Text] [Related]
3. Timentin (ticarcillin/clavulanic acid): lack of antagonism in an in vitro kinetic model, against bacteria producing inducible class-1 beta-lactamase. Slocombe B; Cooper CE; Masters PJ; Warrack JD J Chemother; 1989 Jul; 1(4 Suppl):353-4. PubMed ID: 16312436 [No Abstract] [Full Text] [Related]
4. Effects of clindamycin on derepression of beta-lactamases in gram-negative bacteria. Sanders CC; Sanders WE; Goering RV J Antimicrob Chemother; 1983 Oct; 12 Suppl C():97-104. PubMed ID: 6417103 [TBL] [Abstract][Full Text] [Related]
5. Detection of resistance due to inducible beta-lactamase in Enterobacter aerogenes and Enterobacter cloacae. Huber TW; Thomas JS J Clin Microbiol; 1994 Oct; 32(10):2481-6. PubMed ID: 7814486 [TBL] [Abstract][Full Text] [Related]
6. [Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. I. Effect of sulbactam against beta-lactams resistant strains and in vitro combined effect of sulbactam/cefoperazone with each of piperacillin, latamoxef, ceftazidime, fosfomycin and doxycycline]. Kouda M; Kumagai I; Kobayashi J; Sugai R; Matsuzaki H Jpn J Antibiot; 1990 Apr; 43(4):636-58. PubMed ID: 2199689 [TBL] [Abstract][Full Text] [Related]
7. Effect of beta-lactamase expression on susceptibility of local isolates of Enterobacter cloacae, Serratia marcescens and Pseudomonas aeruginosa to beta-lactam antibiotics. Ramadan MA; Tawfik AF; Shibl AM Chemotherapy; 1995; 41(3):193-9. PubMed ID: 7656665 [TBL] [Abstract][Full Text] [Related]
8. [Synergy between sulbactam and ampicillin or cefoperazone in antimicrobial activity against beta-lactamase producing microorganisms. Results with the use of microdilution broth method]. Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K Jpn J Antibiot; 1990 Jul; 43(7):1214-24. PubMed ID: 2232151 [TBL] [Abstract][Full Text] [Related]
9. [The inducibility of Amp C enzyme of Enterobacter cloacae and its susceptibility to enzyme inhibitor]. Zhang Y; Li J; Zhao M Zhonghua Yi Xue Za Zhi; 2001 Feb; 81(4):227-30. PubMed ID: 11798880 [TBL] [Abstract][Full Text] [Related]
10. Suppressive effect of clindamycin on development of beta-lactam resistance in Enterobacter cloacae ATCC 23355. Tateda K; Ishii Y; Matsumoto T; Hirakata Y; Yamaguchi K J Antimicrob Chemother; 1994 Aug; 34(2):281-6. PubMed ID: 7814290 [No Abstract] [Full Text] [Related]
11. Type I beta-lactamases of Enterobacter cloacae and resistance to beta-lactam antibiotics. Tejedor-Junco MT; González-Martín M; Lupiola P; González-Lama Z Folia Microbiol (Praha); 1998; 43(6):683-6. PubMed ID: 10069013 [TBL] [Abstract][Full Text] [Related]
12. [Antimicrobial susceptibility and prevalence of beta-lactamase producing clinical isolates in southern Kyushu. The results of collaborative study from 1999 to 2000]. Nakasone I; Onaga S; Fukunaga H; Saitoh H; Yamane N; Sato Y Jpn J Antibiot; 2002 Sep; 55 Suppl A():95-110. PubMed ID: 12599533 [TBL] [Abstract][Full Text] [Related]
13. [Beta-lactam resistance in aquatic Enterobacter cloacae strains using phenotypic and genotypic criteria]. Lazăr V; Cernat R; Balotescu C; Cotar A; Coipan E; Cojocaru C Bacteriol Virusol Parazitol Epidemiol; 2002; 47(3-4):185-91. PubMed ID: 15085610 [TBL] [Abstract][Full Text] [Related]
15. Effects of inducible beta-lactamase and antimicrobial resistance upon the activity of newer beta-lactam antibiotics against Pseudomonas aeruginosa. Hoffman TA; Cleary TJ; Bercuson DH J Antibiot (Tokyo); 1981 Oct; 34(10):1334-40. PubMed ID: 6796556 [TBL] [Abstract][Full Text] [Related]
16. Kinetics of Sulbactam Hydrolysis by β-Lactamases, and Kinetics of β-Lactamase Inhibition by Sulbactam. Shapiro AB Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971872 [TBL] [Abstract][Full Text] [Related]
17. [Resistance caused by hyperproduction of chromosomal beta-lactamase in Pseudomonas aeruginosa]. Tirado M; Hermida M; Reig R; Esteva C; Vidal R; Roy C Enferm Infecc Microbiol Clin; 1989 Dec; 7(10):530-4. PubMed ID: 2518765 [TBL] [Abstract][Full Text] [Related]
18. Beta-lactamase expression and cross-resistance to beta-lactam antibiotics in a nosocomial population of Enterobacter. Steffee CH; Wasilauskas BL Chemotherapy; 1992; 38(5):291-6. PubMed ID: 1286572 [TBL] [Abstract][Full Text] [Related]
19. The effects on beta-lactam susceptibility of phenotypic induction and genotypic derepression of beta-lactamase synthesis. Shannon K; Phillips I J Antimicrob Chemother; 1986 Dec; 18 Suppl E():15-22. PubMed ID: 3102451 [TBL] [Abstract][Full Text] [Related]
20. [Sensitivity of Pseudomonas aeruginosa to beta-lactam antibiotics and effects of beta-lactamases]. Avril JL; Cayla AM; Guist'hau O; Moillo-Batt A Pathol Biol (Paris); 1983 Jun; 31(6):471-5. PubMed ID: 6410345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]